Table 3.
Baseline characteristics of study subjects
| TC | WBV | Con | F/χ2 | P | |
|---|---|---|---|---|---|
| N | 24 | 28 | 27 | – | – |
| Age (year) | 88.8 ± 3.7 | 89.5 ± 4. 4 | 87.5 ± 3.0 | 1.15 | 0.13 |
| Height (m) | 1.68 ± 0.47 | 1.65 ± 0.25 | 1.63 ± 0.06 | 0.12 | 0.89 |
| Weight (kg) | 63.1 ± 6.6 | 64.2 ± 6.7 | 66.2 ± 10.5 | 0.61 | 0.55 |
| BMI (kg/m2) | 22.4 ± 3.1 | 22.5 ± 2.2 | 23.5 ± 3.9 | 0.91 | 0.41 |
| Medications, category | 4.6 ± 3.4 | 5.4 ± 2.7 | 5.8 ± 3.3 | 1.92 | 0.59 |
Medications include: 1) neurological drugs: tranquilizers, hypnotics, antianxiety, antidepressants; 2) cardiovascular drugs: antihypertensive drugs, vasodilators, anticoagulants; 3) analgesics; 4) hypoglycemic agents; 5) antibiotics; and 6) others
TC the Tai Chi group, WBV the whole-body vibration group, CON the control group, BMI body mass index (kg/m2)